tamibarotene has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Azim, H; He, Q; Khazal, S; Kim, YM; Li, L; Lou, S; Prasadarao, NV; Qi, X; Shimada, H; Shudo, K; Sun, W; Warburton, D; Wu, L; Zhou, A; Zhu, H | 1 |
| Ding, W; He, Q; Li, L; Mittal, R; Prasadarao, NV; Shimada, H; Shudo, K; Wu, L; Zhang, X | 1 |
2 other study(ies) available for tamibarotene and Neutropenia
| Article | Year |
|---|---|
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.
Topics: Animals; Antineoplastic Agents; Bacteremia; Benzoates; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Mice; Neutropenia; Neutrophils; Survival Analysis; Tetrahydronaphthalenes | 2016 |
Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.
Topics: Animals; Antigens, CD; Bacteria; Benzoates; Blotting, Western; CD18 Antigens; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Cyclophosphamide; Cytoplasmic Granules; Disease Models, Animal; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Humans; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Neutropenia; Neutrophils; Phagocytosis; Retinoids; Tetrahydronaphthalenes | 2013 |